Medtronic, FDA and Parkinson's

In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive technology personalizing treatment of Parkinson’s symptoms using advanced stimulation deep in the brain.
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s
Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous system.
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation ap | The company said its U.
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.
Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no
FDA approves Medtronic’s adaptive technology for Parkinson’s
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
Parkinson’s Patients Have a New Way to Manage Their Symptoms
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream
Medtronic ( MDT 2.27%) and Johnson & Johnson ( JNJ 1.64%) are two very healthy, high-yielding dividend stocks. This makes ...
North Haven targets adding shops and restaurants as Medtronics possibly expands
First Selectman Michael Freda said he's working with Medtronics to improve the area around its North Haven site though the ...
Medtronic expects pressure in surgical unit for fourth quarter, shares fall
Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...
Medtronic’s stock drops on inventory hiccup and revenue miss
Jeff Jonas, portfolio manager at Gabelli Funds, said he’s surprised at the drop in Medtronic’s stock on the heels of its ...
devdiscourse7h
Health Industry Updates: Key Developments and Investments
Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...
Truist Financial Remains a Hold on Medtronic (MDT)
Truist Financial analyst Richard Newitter maintained a Hold rating on Medtronic (MDT – Research Report) on February 23 and set a price target ...
manilatimes2h
Medtronic Malaysia and Malaysian Society of Colorectal Surgeons sign MOU to enhance medical training and education programs
Medtronic plc, a global leader in healthcare technology, announced that Medtronic Malaysia and Malaysian Society of Colorectal Surgeons (MSCRS) have signed a Memorandum of Understanding (MoU) to ...